ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target
Sign Up to like & getrecommendations! Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-70924-z
Abstract: ROR1 and ROR2 are receptor tyrosine kinases with altered expression in a range of cancers. Silencing ROR1 or ROR2 in different tumour types has been shown to inhibit proliferation and decrease metastatic potential. The aim… read more here.
Keywords: ror1 ror2; upregulated endometrial; endometrial cancer; ror1 ... See more keywords